Session

Back to Programme Overview

BLEXIT - best perioperative outcomes from cystectomy

Poster Session 20

  • Location:
    Room Copenhagen, North Hall (Level 1)
  • Chairs:
     P. Anderson, Melbourne (AU)
     P. Gontero, Turin (IT)
  • Aims and objectives of this session

    To understand how to optimize perioperative outcomes in cystectomy.

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
261
Postoperative psoas muscle loss and nutritional deterioration after radical cystectomy for patients with invasive bladder cancer

By: Miyake M.1, Morizawa Y.1, Hori S.1, Marugami N.2, Shimada K.3, Gotoh D.1, Tatsumi Y.1, Nakai Y.1, Anai S.1, Tanaka N.1, Fujimoto K.1

Institutes: 1Nara Medical University, Dept. of Urology, Nara, Japan, 2Nara Medical University, Dept. of Radiology, Nara, Japan, 3Nara City Hospital, Dept. of Pathology, Nara, Japan

262
Robot-assisted laparoscopic cystectomy vs. open mini-laparotomy cystectomy: Evaluation of anti-inflammatory potential of CO2-pneumoperitoneum in a randomized porcine study

By: Kingo P.S.1, Rasmussen T.M.1, Jakobsen L.K.1, Palmfeldt J.2, Borre M.1, Nørregaard R.2, Jensen J.B.1

Institutes: 1Aarhus University Hospital, Skejby, Dept. of Urology, Aarhus N, Denmark, 2Aarhus University Hospital, Skejby, Dept. of Clinical Medicine, Aarhus N, Denmark

263
Withdrawn

By:

Institutes:

264
20-gene expression signature to predict lymph node positive disease at radical cystectomy for muscle-invasive bladder cancer: Not validated

By: Van Kessel K.1, Van De Werken H.2, Lurkin I.1, Ziel–Van Der Made A.1, Zwarthoff E.1, Boormans J.3

Institutes: 1Erasmus MC, Dept. of Pathology, Rotterdam, The Netherlands, 2Erasmus MC, Cancer Computational Biology Center (CCBC), Rotterdam, The Netherlands, 3Erasmus MC, Dept. of Urology, Rotterdam, The Netherlands

265
The use of antibiotic prophylaxis in patients undergoing radical cystectomy for bladder cancer

By: Haider M.1, Mayr R.1, Fritsche H-M.1, Ladurner C.2, Pycha A.2, Comploj E.2, Lemire F.3, Lacombe L.3, Fradet Y.3, Lodde M.3

Institutes: 1University of Regensburg, Dept. of Urology, Regensburg, Germany, 2General Hospital of Bolzano, Dept. of Urology, Bolzano, Italy, 3Laval University, Dept. of Urology, Québec, Canada

266
Can radical cystectomy be performed safely in the metastatic setting? Location of metastatic bladder cancer as a determinant of in-hospital mortality

By: Zaffuto E.1, Moschini M.1, Leyh-Bannurah S-R.2, Gazdovich S.3, Dell’Oglio P.1, Pompe R.2, Shariat S.4, Montorsi F.1, Briganti A.1, Saad F.5, Karakiewicz P.3

Institutes: 1IRCCS Ospedale San Raffaele, Division of Oncology/Unit of Urology; URI, Milan, Italy, 2Prostate Cancer Center Hamburg-Eppendorf, Martini-Clinic, Hamburg, Germany, 3University of Montreal Health Center, Cancer Prognostics and Health Outcomes Unit, Montreal, Canada, 4Medical University of Vienna, Dept. of Urology, Vienna, Austria, 5University of Montreal Health Center, Dept. of Urology, Montreal, Canada

267
Increasing use of incontinent urinary diversion: A total population analysis of radical cystectomies in Germany from 2006 to 2013

By: Groeben C.1, Koch R.2, Baunacke M.1, Wirth M.1, Huber J.1

Institutes: 1TU Dresden, Medical Faculty Carl Gustav Carus, Dept. of Urology, Dresden, Germany, 2TU Dresden, Medical Faculty Carl Gustav Carus, Dept. of Medical Statistics and Biometry, Dresden, Germany

268
Incidence and risk factors for venous thromboembolism after transurethral resection of bladder tumor: A population-based analysis

By: Zaffuto E.1, Pompe R.2, Moschini M.1, Bondarenko H.D.3, Dell’Oglio P.1, Fossati N.1, Gandaglia G.1, Gallina A.1, Shariat S.F.4, Montorsi F.1, Briganti A.1, Karakiewicz P.I.5

Institutes: 1IRCCS Ospedale San Raffaele, Dept. of Oncology and Urology, Milan, Italy, 2Prostate Cancer Center Hamburg-Eppendorf, Martini-Clinic, Hamburg, Germany, 3University of Montreal Health Center, Cancer Prognostics and Health Outcomes Unit, Montreal, Canada, 4Medical University of Vienna, Dept. of Urology, Vienna, Austria, 5University of Montreal Health Center, Dept. of Cancer Prognostics and Health Outcomes, Montreal, Canada

269
Diarrhea as a limiting factor of quality of life after radical cystectomy: Results from a cross-sectional study evaluating long-term bowel issues in bladder cancer patients

By: Hupe M.C.1, Vahlensieck W.2, Hennig M.1, Ozimek T.1, Struck J.1, Tezval H.3, Merseburger A.1, Kuczyk M.3, Kramer M.1

Institutes: 1University Hospital Schleswig-Holstein, Campus Luebeck, Dept. of Urology, Luebeck, Germany, 2Kurpark-Klinik, Dept. of Urology, Bad Nauheim, Germany, 3Hanover Medical School, Dept. of Urology, Hanover, Germany

270
Low psoas muscle volume indicates long hospitalization after radical cystectomy

By: Kawahara T., Saitoh Y., Miyoshi Y., Uemura H.

Institutes: Yokohama City University Medical Center, Dept. of Urology and Renal Transplantation, Yokohama, Japan

271
Efficacy of long acting sandostatin on reducing mucus production in patients with ileal neobladder

By: Khorrami M.H.

Institutes: Isfahan University of Medical Sciences, Dept. of Urology, Isfahan, Iran

272
The BAUS radical cystectomy audit 2014/2015 - an update on current practice and an analysis of the effect of centre and surgeon case volume

By: Khadhouri S.1, Miller C.1, Cresswell J.2, Rowe E.3, Fowler S.4, Hounsome L.5, McGrath J.S.1

Institutes: 1Royal Devon and Exeter Hospital, Dept. of Urology, Exeter, United Kingdom, 2South Tees NHS Trust, Dept. of Urology, Middlesbrough, United Kingdom, 3North Bristol NHS Trust, Dept. of Urology, Bristol, United Kingdom, 4BAUS, Dept. of Surgery, London, United Kingdom, 5Public Health England, Dept. of Public Health, London, United Kingdom

273
Pure histological variants are associated with poor survival at radical cystectomy in patients with bladder cancer

By: Moschini M.1, Colombo R.1, Gandaglia G.1, Di Trapani E.1, Burgio G.1, Damiano R.2, Mattei A.3, Shariat S.4, Salonia A.1, Briganti A.1, Montorsi F.1, Gallina A.1

Institutes: 1IRCCS Ospedale San Raffaele, Dept. of Urology, Milan, Italy, 2Magna Graecia University of Catanzaro, Dept. of Urology, Catanzaro, Italy, 3Luzerner Kantonsspital, Dept. of Urology, Lucerne, Switzerland, 4Medical University of Vienna, Dept. of Urology, Vienna, Austria

274
Comparative effectiveness of trimodal therapy versus radical cystectomy for localized muscle-invasive urothelial carcinoma of the bladder

By: Seisen T.1, Sun M.1, Lipsitz S.2, Abdollah F.3, Leow J.1, Menon M.3, Von Landenberg N.1, Gild P.1, Rouprêt M.4, Preston M.1, Harshman L.5, Kibel A.S.1, Nguyen P.6, Bellmunt J.5, Choueiri T.5, Trinh Q.-D.1

Institutes: 1Brigham and Women’s Hospital, Harvard Medical School, Division of Urological Surgery and Center For Surgery and Public Health, Boston, United States of America, 2Brigham and Women’s Hospital, Harvard Medical School, Division of Urological Surgery and Center For, Boston, United States of America, 3Henry Ford Health System, VUI Center For Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Detroit, United States of America, 4Pitié-Salpêtrière, APHP, University Paris VI, Dept. of Urology, Paris, France, 5Dana Farber Cancer Institute, Dept. of Medical Oncology, Boston, United States of America, 6Brigham and Women’s Hospital, Harvard Medical School, Dept. of Radiation Oncology, Boston, United States of America

Summary
 P. Anderson, Melbourne (AU)